Trend: Bullish structure with SMA_5 > SMA_20 > SMA_200, indicating an established uptrend.
Momentum: MACD histogram at +0.137 and expanding supports ongoing upside momentum.
Overbought/extension: RSI_6 = 79.204 suggests the move is extended short-term (prone to pauses/pullbacks).
Levels: Current pre-market 21.93 is close to R1 (22.065). A clean breakout above R1 targets R2 (22.73). Failure near R1 increases odds of a dip toward pivot (20.99) and S1 (~19.91).
Pattern-based stats provided: near-term edge looks small (next day +0.65%) and slightly negative over the next week (-0.63%), with a stronger 1-month bias (+15.67%)—implying better entries may appear on a pullback rather than buying into resistance.
Options Data
Neutral
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning (Open Interest): Put/Call OI ratio 0.97 (roughly balanced, not strongly bullish or bearish).
Activity (Volume): Options volume is effectively zero today (limited real-time sentiment signal).
Volatility: 30D IV ~91.26 vs historical vol ~37.79; IV percentile 86.8 indicates options are priced for elevated uncertainty (market expects larger moves than recent history).
Technical Summary
Sell
5
Buy
9
Positive Catalysts
Q4 revenue reported at $39.86M, indicating solid performance in lending/deposit businesses.
Neutral/Negative Catalysts
and price sitting just below resistance (R1 ~22.
increases odds of a near-term stall/pullback.
Financial Performance
Latest quarter season provided in financial snapshot: 2025/Q3.
2025/Q3 revenue: $36.763M, +14.91% YoY (top-line growth trend is positive).
News (Q4): GAAP EPS $0.38 and revenue $39.86M suggest continued operational stability into year-end 2025.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
[2025-12-25] Freedom Capital initiated coverage at Buy with a $23 price target.
Rating/target trend: only one recent initiation provided (no series of upgrades/downgrades), so sentiment from Wall Street data here is mildly positive but limited in breadth.
Wall Street pro view (pros): regional growth story, loan expansion, improving margins, stable core deposits.
Wall Street con view (cons): limited analyst breadth disclosed; continued profitability improvement needs to show through consistently (given Q3 net income was down YoY).
Wall Street analysts forecast CARE stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CARE is 22 USD with a low forecast of 22 USD and a high forecast of 22 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast CARE stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CARE is 22 USD with a low forecast of 22 USD and a high forecast of 22 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 22.010
Low
22
Averages
22
High
22
Current: 22.010
Low
22
Averages
22
High
22
Freedom Capital
Buy
initiated
$23
AI Analysis
2025-12-25
Reason
Freedom Capital
Price Target
$23
AI Analysis
2025-12-25
initiated
Buy
Reason
Freedom Capital initiated coverage of Carter Bankshares with a Buy rating and $23 price target. The firm says Carter offers a "regionally focused growth story" with loan expansion, improving margins, and a stable core deposit base across its Virginia and North Carolina markets. The bank is on a path to higher profitability, the analyst tells investors in a research note.
